GLP-1 drugs tied to lower breast cancer incidence in large study
Women who used GLP-1 medications were about 30 percent less likely to develop breast cancer than similar women who did not use the drugs, according to a new retrospective study led by researchers at University of Pennsylvania
Can vitamin D enhance breast cancer response to chemotherapy?
Low doses of vitamin D can enhance the effectiveness of chemotherapy given to women being treated for breast cancer.
Injecting a redesigned immunotherapy drug directly into a cancer tumor triggered response in metastatic tumors
Patients with a variety of solid tumors saw cancerous tumors that a had spread to other parts of their bodies shrink when the primary tumor was injected with a re-engineered antibody immunotherapy.
Risk-based breast cancer screening may be more efficient than age-based guidelines
Individually-tailored risk-based screening may be a more efficient way to screen for breast cancer. Image credit – National Cancer Institute CANCER DIGEST – Jan. 18, 2026 – Tailoring breast cancer screening to individual risk factors as opposed to relying on age guidelines may be a better way to reduce the chance of advanced cancer at diagnosis, a major screening study shows. The WISDOM study enrolled 46,000 women from all 50 states between 2016 and 2023. The aim was to compa
Study shows more aggressive breast cancer than expected for younger women
Women under 50 are being diagnosed with cancer more often than screening guidelines predict, with a large percentage of these cancers being invasive and harder to treat.
Living near a Superfund pollution site may boost risk of aggressive types of breast cancer
Women diagnosed with breast cancer have a higher risk of aggressive and hard to treat cancers if they live near an EPA designated Superfund site.
